Lineage Cell Therapeutics In shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $475k | 321k | 1.48 |
| 2023-12-31 | $390k | 358k | 1.09 |
| 2023-09-30 | $421k | 357k | 1.18 |
| 2023-06-30 | $503k | 357k | 1.41 |
| 2023-03-31 | $106k | 71k | 1.50 |
| 2022-12-31 | $82k | 71k | 1.16 |
| 2022-09-30 | $0 | 71k | 0.00 |
| 2022-06-30 | $112k | 71k | 1.58 |
| 2022-03-31 | $633k | 411k | 1.54 |
| 2021-12-31 | $0 | 421k | 0.00 |
| 2021-09-30 | $0 | 425k | 0.00 |
| 2021-06-30 | $1.1M | 381k | 2.85 |
| 2021-03-31 | $171k | 73k | 2.35 |
| 2020-12-31 | $144k | 82k | 1.76 |
| 2020-09-30 | $74k | 79k | 0.94 |
| 2020-06-30 | $0 | 79k | 0.00 |
| 2020-03-31 | $340k | 411k | 0.83 |
| 2019-12-31 | $441k | 496k | 0.89 |
| 2019-09-30 | $447k | 456k | 0.98 |